What’s New in CGMs & Insulin Pumps (and Why You Might Get Excited)
The American Diabetes Association’s 85th Scientific Sessions were held last weekend, and I promised I would write another review devoted to diabetes tech. If you’re interested in fewer finger pricks and more freedom, there was a lot to get excited about. From longer-lasting sensors to more innovative, sleeker pumps, here’s your friendly guide to the most significant tech updates that could be coming to your diabetes toolbox soon.
What’s New in Continuous Glucose Monitors (CGMs)
Dexcom G7 – Now Lasts Even Longer
Dexcom’s G7 just got a glow-up! The FDA gave a thumbs-up in April to a 15-day version of the G7 (with an extra 12-hour grace period), making it the longest-lasting Dexcom sensor yet—and one of the most accurate (MARD 8.0%).
If you’ve been annoyed by frequent sensor changes, this might feel like a mini vacation. It’s expected to hit the market in late 2025 and will work with automated insulin delivery (AID) systems soon after.
👉 Official Dexcom announcement
Abbott’s Glucose + Ketone Sensor – Double Duty
Imagine one sensor that watches both glucose and ketones—like a tiny bodyguard against DKA. Abbott is working on exactly that. This dual sensor could help people with type 1 diabetes catch rising ketones before things get serious.
And since their announcement, they’ve been busy, like really busy. Tandem, Sequel, and Beta Bionics have all lined up to work with it.
👉 More on Abbott’s agreement with Sequel
👉 Moore on Abbott’s agreement with Tandem
👉 More on Abbott’s agreement with Beta Bionics
Eversense 365 – A Year-Long Sensor, Now in a Loop
If the idea of inserting a CGM only once a year sounds magical, meet the Eversense 365. It’s an implantable CGM that lasts a full year (yes, 365 days) and now works with the Twiist AID system—a new pump app developed by Tidepool.
👉More on Eversense’s agreement with Sequel
Bonus: They’re working on more partnerships, so integration with other pumps is on the horizon.
👉More on Eversense’s possibility of working with other pumps
The Latest in Insulin Pumps
Omnipod 5 – Now iPhone‑Friendly
Insulet shared exciting data showing that people using Omnipod 5 saw lower A1Cs and less diabetes stress (we’ll take both, thanks).
👉 More on the SECURE‑T2D and RADIANT trials
It’s now compatible with iPhones and the Dexcom G7, making it even easier to ditch the tubes and carry one less device.
👉 More on the IPhone update for the G7
Medtronic’s Makeover: Smaller, Smarter, and Patchier
Medtronic previewed two new devices:
- MiniMed 8-series: It’s half the size of the 780G, ditching the screen in favor of smartphone control.
- Patch pump: A semi-durable patch pump with a 300-unit reservoir, rechargeable battery, and 7-day wear—kind of like a luxury hybrid car, but for insulin delivery.
FDA clearance for the 8-series is expected by April 2026.
👉 More at Diabetech about Medronic’s planned pumps
Beta Bionics “Mint” Patch Pump – Fresh Tech, Literally
Beta Bionics is working on a new patch pump called Mint—and no, it’s not scented (yet). It has:
- A reusable controller that lasts ~2 years
- 3-day disposable pods (with 200 units of insulin)
- No recharging needed—the batteries are built into the pods
- Compatibility with Dexcom G7 and Libre 3 Plus
Mint is expected to arrive in the U.S. by the end of 2027, if all goes well with FDA approval.
Tandem’s Trio of Tech
Tandem is getting busy. They’re working on:
- t:slim X3 – Better battery, processor, and durability
- Mobi Tubeless – Their smallest, screenless option
- Sigi Patch Pump – Rechargeable, with prefilled insulin cartridges (because filling pods manually is sooo 2023)
The X3 is likely coming first, followed by Mobi and Sigi.
👉Read about Tandem’s plans on MedTechDive
Sequel’s New Pump Drops July 7
The buzz has been about Sequel MedTech entering the game with a brand-new pump launching July 7, 2025. For all of the details to see if it lives up to the hype (it does) check out Diabetech.
👉 Read more about the twiist at Diabetech
AID for Type 2 Diabetes
Big win: The FDA recently expanded approvals for both Omnipod 5 and Tandem Control-IQ to be used in people with type 2 diabetes.
Medtronic is working to join them, aiming to expand its 780G pump to include type 2 use—stay tuned as more data rolls out from ADA.
🧠 Final Thoughts
From longer-lasting sensors to phone-powered pumps, 2025 is shaping up to be a banner year in diabetes care. Whether you’re tech-savvy or just want less diabetes in your day-to-day, these innovations are aimed at making life smoother, safer, and just a little bit cooler.
💬 Got thoughts? Excited about one of these devices? Drop a comment and let’s geek out together. ’s geek out together.